Clinical trial
Pilot Study of Pemetrexed for the Treatment of Chordoma
NCT03955042 is registered in ClinicalTrials.gov with Saint John's Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Pemetrexed for the Treatment of Chordoma
- Lead sponsor
- Saint John's Cancer Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 6, 2019
- Completion date
- January 18, 2023
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.